Genmab, AbbVie data boosts Epkinly as first-line B-cell lymphoma treatment
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
MAGAnomics is starting to look uncomfortably like Bidenomics
Trump once called Biden-era inflation a “country-buster” and a “colossal tax on American families.” Now the shoe is on the other foot.
NGX slips 0.06% as Nestlé, insurers drag market lower
The Nigerian Exchange equity market closed on a slightly negative note on Monday, October 5, 2026, as the NGX All-Share Index (ASI) slipped by 140.41 points to close at 250,667.86 points, compared to…
Nasdaq hits record high as investors focus on earnings
The Nasdaq hit an all-time high on Monday, lifted by Nvidia and Microsoft, as investors focused on a dip in oil prices and looked ahead to quarterly earnings reports.
Euro hits 17-month low as French debt fears, US inflation lift dollar
The euro reached a 17-month low against the dollar due to worries over France's budget deficit. Concerns about a potential euro-zone debt crisis have heightened market caution amid political…
Petrobras, Cosan, Compass: as favoritas do Bradesco para um Governo Flávio
O resultado do primeiro turno fez o mercado revisitar suas teses para surfar uma provável mudança no Palácio do Planalto em 2027.
Why Pfizer Might Be the Most Underrated Dividend Stock to Buy Right Now
Many dividend investors may be overlooking Pfizer's stock, and that could be a costly mistake.